Brad H Rovin Selected Research

apolipoprotein E2 (Kyoto)

10/2010	A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
12/2007	APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brad H Rovin Research Topics

Disease

49	Lupus Nephritis 01/2022 - 10/2006
25	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2021 - 07/2002
24	Proteinuria 01/2022 - 03/2004
18	Inflammation (Inflammations) 01/2022 - 08/2001
12	Nephritis 01/2019 - 07/2002
9	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2022 - 12/2004
9	Glomerulonephritis 08/2021 - 07/2002
8	Infections 01/2022 - 10/2002
8	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2010
8	Chronic Renal Insufficiency 01/2019 - 11/2009
7	Kidney Diseases (Kidney Disease) 02/2021 - 10/2009
7	Diabetic Nephropathies (Diabetic Nephropathy) 11/2018 - 03/2004
6	IGA Glomerulonephritis (IGA Nephropathy) 10/2021 - 05/2016
5	Chronic Kidney Failure (Chronic Renal Failure) 06/2022 - 12/2008
5	Autoimmune Diseases (Autoimmune Disease) 02/2021 - 06/2007
5	Hematuria 01/2021 - 10/2011
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2018 - 03/2004
3	COVID-19 09/2022 - 01/2020
3	Vasculitis (Vasculitides) 10/2021 - 01/2017
3	Anemia 11/2020 - 02/2013
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2020 - 01/2010
3	Diabetes Mellitus 09/2017 - 07/2006
3	Hypertension (High Blood Pressure) 05/2017 - 01/2012
2	Fibrosis (Cirrhosis) 01/2022 - 08/2012
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2021 - 08/2020
2	Hemorrhage 11/2020 - 06/2013
2	Necrosis 10/2020 - 08/2012
2	Body Weight (Weight, Body) 01/2020 - 01/2019
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 09/2008
2	Obesity 04/2012 - 07/2006
2	Atherosclerosis 04/2012 - 05/2006
2	Lipoprotein Glomerulopathy 10/2010 - 12/2007
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 10/2021
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 10/2021
1	Hypercholesterolemia 01/2021

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2005
22	CreatinineIBA 01/2022 - 10/2005
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
15	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 04/2005
10	Rituximab (Mabthera)FDA Link 01/2022 - 12/2008
9	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2010
7	Antigen-Antibody Complex (Immune Complex)IBA 02/2021 - 07/2002
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 12/2004
6	AutoantibodiesIBA 02/2021 - 09/2014
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2021 - 05/2016
5	Complement System Proteins (Complement)IBA 02/2021 - 01/2004
5	Calcineurin InhibitorsIBA 01/2021 - 05/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 12/2008
5	ChemokinesIBA 01/2008 - 08/2001
4	AntibodiesIBA 01/2022 - 01/2009
4	GlucocorticoidsIBA 01/2021 - 08/2005
4	Antinuclear AntibodiesIBA 01/2019 - 01/2017
4	HepcidinsIBA 04/2015 - 12/2010
3	belimumabIBA 01/2022 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 08/2021 - 12/2008
3	Immunoglobulin G (IgG)IBA 02/2021 - 01/2016
3	Immunoglobulin A (IgA)IBA 12/2020 - 05/2007
3	Cytotoxins (Cytolysins)IBA 10/2016 - 12/2008
3	Monoclonal AntibodiesIBA 01/2016 - 12/2008
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2015 - 10/2002
3	ProteomeIBA 05/2012 - 03/2004
3	CytokinesIBA 12/2010 - 08/2001
3	AdiponectinIBA 07/2009 - 10/2005
3	Complement C4 (Complement Component 4)IBA 06/2007 - 01/2004
2	Azathioprine (Imuran)FDA LinkGeneric 01/2022 - 01/2020
2	Bortezomib (Velcade)FDA Link 08/2021 - 06/2020
2	Pancreatic Elastase (Elastase)IBA 08/2021 - 03/2004
2	Dabigatran FDA Link 01/2021 - 02/2015
2	voclosporinIBA 01/2021 - 01/2019
2	AnticoagulantsIBA 01/2021 - 02/2015
2	IronIBA 01/2021 - 03/2011
2	Pharmaceutical PreparationsIBA 11/2020 - 01/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 01/2015
2	inositol pentaphosphate (inositol pentakisphosphate)IBA 11/2018 - 09/2009
2	SteroidsIBA 01/2018 - 08/2005
2	Peptides (Polypeptides)IBA 01/2017 - 09/2009
2	Prednisone (Sone)FDA LinkGeneric 01/2017 - 08/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2009
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2016 - 12/2004
2	bromfenacoum (Ratak)IBA 01/2015 - 10/2011
2	AutoantigensIBA 12/2014 - 09/2014
2	apolipoprotein E2 (Kyoto)IBA 10/2010 - 12/2007
2	ProstaglandinsIBA 09/2005 - 08/2001
1	felzartamabIBA 09/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	obinutuzumabIBA 01/2022
1	ocrelizumabIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 08/2021
1	daratumumabIBA 08/2021
1	Complement C5 (Complement 5)IBA 08/2021
1	AntigensIBA 02/2021
1	moesinIBA 02/2021
1	COVID-19 VaccinesIBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021

Therapy/Procedure

34	Therapeutics 09/2022 - 12/2004
4	Nephrectomy 01/2021 - 05/2007
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 01/2019
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 12/2008
2	Lasers (Laser) 05/2012 - 09/2009